Esperion Therapeutics
ESPR
#6497
Rank
A$1.16 B
Marketcap
A$4.52
Share price
0.32%
Change (1 day)
168.62%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.71. In 2024 the company made an earnings per share (EPS) of A-$0.33 an increase over its 2023 EPS that were of A-$3.02.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79139.66%
2024A-$0.33-89.15%
2023A-$3.02-40.28%
2022A-$5.06-62.87%
2021A-$13.6380.38%
2020A-$7.5550.14%
2019A-$5.03-53.18%
2018A-$10.757.41%
2017A-$10.01110.81%
2016A-$4.7547.35%
2015A-$3.220.89%
2014A-$3.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.87-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.62-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.71 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.00-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA